Have you had separate experiences with psychedelics and cannabis? If so, take our survey! tinyurl.com/psyches-cann... Your responses help us understand these compounds better, so that we can continue to expand the science of psychedelics and knowledge about their risks and benefits.

Thanks Dr. Chuck Nichols for presenting at the CPCR journal club! Watch Dr. Nichols' full presentation on using preclinical models to investigate the therapeutic potential of psychedelics 🔗👇

CPCR Faculty David Yaden was quoted in the New Yorker on one of the more interesting scientific questions in the field of psychedelics - what role (if any) the psychedelic experience has in their persisting effects www.newyorker.com/culture/anna...

It's not too late to sign up for our upcoming continuing education course on March 26th! Learn from our expert faculty and earn up to 6.5 CE/CMEs

Wondering what clinicians should know about psychedelic-assisted treatments? tinyurl.com/hopkinscme Join our upcoming CME/CE course designed to help clinicians engage with patients, understand new research, and prepare for the future of psychedelic-assisted care.

New findings from a pilot randomized trial of psilocybin for smoking cessation are now published in JAMA Open Network — this is one of the largest controlled trials of psilocybin for substance use disorder, with promising results! jamanetwork.com/journals/jam...

Thrilled to announce our new CME course on psychedelic medicine, taught by CPCR faculty! Designed for physicians, advanced practice providers, mental health clinicians, & anyone interested in psychedelic medicine. ✔ Up to 6.5 CME/CE credits 📅 March 27, 2026 | Live Online 🔗 tinyurl.com/hopkinscme

Ready for a weekend of science at the International Society for Research on Psychedelics (ISRP)

New pilot study from Johns Hopkins finds psilocybin-assisted treatment was associated with significant and sustained benefits in post-treatment Lyme disease, including improved mood, fatigue, sleep, pain, and quality of life for up to 6 months. More research is needed to confirm. Read more below 👇

Huge congratulations to Dr. Albert Garica-Romeu who was recently named a Frontiers of Science Fellow by the National Academy of Sciences! tinyurl.com/2cbkt93c

A new review in Psychiatric Times examines adverse event data for psilocybin, MDMA, ketamine, and ibogaine, finding meaningful differences in risk and inconsistent reporting. Clear compound-level distinctions are crucial as access expands. www.psychiatrictimes.com/view/adverse...

Dr. Fred Barrett co-authored a new paper on the challenges of running rigorous psychedelic clinical trials — from expectancy effects to blinding. As therapies near FDA approval, strong science is essential. Read more: journals.sagepub.com/doi/10.1177/...

🔬 We are hiring a Research Data Analyst. Learn more and apply: hiring.jhu.edu/careers?quer...

Dr. Brandon Weiss explores how MDMA and psilocybin may help rewire fear patterns in PTSD, including a new PAMVET trial on combining the two. Learn more below.https://www.livescience.com/health/mind/psychedelics-may-rewire-the-brain-to-treat-ptsd-scientists-are-finally-beginning-to-understand-how

CPCR Medical Director Dr. Sandeep Nayak weighs in on where psilocybin therapy for PTSD is headed – from policy shifts to clinical progress and what it means for the future of care www.lucid.news/legislation-...

We're excited to unveil our redesigned CPCR website! Whether you're interested in participating in cutting-edge clinical trials, exploring our research publications, or accessing information about our integration clinic and online courses. Check it out! hopkinspsychedelic.org

Can psilocybin assisted therapy reduce opioid use and improve quality of life? We are seeking people near Baltimore, Maryland with Opioid Use Disorder to participate in a trial to see if psilocybin can reduce opioid use and improve quality of life. jhmi.co1.qualtrics.com/jfe/form/SV_...

The Psychedelic Archives Project Guest Speaker Series continues this Wednesday with Dr. Nicolas Langlitz. 🗓 February 11th, 2026 | ⏰ 4:30 PM EST 🎟 Attendance is free — registration link below 👇 jhubluejays.zoom.us/j/92622903856

Ongoing debate about psychological support versus psychotherapy in psychedelic trials often stems from vague definitions. Clarifying these constructs is essential for rigorous study of safety and efficacy.

Join us Wednesday for the Psychedelic Archives Project Guest Speaker Series! 🎤 Dr. Larissa Carneiro 🗓 January 28, 2026 | ⏰ 4:30 PM EST 🎟 Free to attend — sign up at the link below! 👇 jhubluejays.zoom.us/j/92622903856

Have you had separate experiences with psychedelics and cannabis? Take our short survey to help expand research on their effects: tinyurl.com/psyches-cann...

Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based insight into how they work and who may benefit. Ideal for clinicians, students, researchers, and curious learners. Enroll below 👇

SEEKING HEALTHY VOLUNTEERS FOR A PSYCHEDELIC STUDY 🔗 tinyurl.com/34jnz3d5 📞 410-550-2253 ✉️ [email protected]

Dr. Brandon Weiss spoke on psychedelic therapy at the AcademyHealth conference for VA clinicians. Thanks to Dr. Matthew Boehm and fellow panelists. CPCR is focused on implementing these therapies in healthcare.

Join us- the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on today Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇 jhubluejays.zoom.us/j/92622903856

Want to help researchers better understand how psychedelic experiences impact mood and cognitive functioning? Please take part in our anonymous survey! jhmi.co1.qualtrics.com/jfe/form/SV_...

Next up in the Psychedelic Archives Project guest speaker series is Dr. Catherine Freddo, presenting on Jan 7, 2025 at 4:30pm EST. Join for free at the link below! 👇 jhubluejays.zoom.us/j/92622903856

On Thursday December 11, it was Dr. Brandon Weiss', Dr. Fred Barrett's, and Dr. Bit Yaden's honor to host Bradley Plunkett, Mikayla Harris, and Katie Johnston, professional staff members of Senator Jerry Moran, Chairman of the Senate Committee of Veteran Affairs More details: x.com/JHPsychedeli...

On Tuesday December 9, CPCR Director Dr. Fred Barrett and Assistant Professor Dr. Brandon Weiss took part in a roundtable exchange among VA representatives, researchers, and veteran groups organized by the Senate Committee on Veteran Affairs. For more details: x.com/JHPsychedeli...

Dr. David Yaden was interviewed by The Harvard Gazette on the need for large, rigorous NIH-funded psychedelic research.

Our new review is out! 🎉 link.springer.com/article/10.3... We pull together behavioral and neuroimaging evidence showing that psychedelics not only shift perception and emotion but also influence how the brain handles cognitive control.

We review evidence that psychedelics disrupt executive function acutely but post-acutely enhance cognitive flexibility via increased executive network connectivity, though more research is needed.

Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based education on how they work & who they may help.Perfect for clinicians, students, researchers, or anyone wanting reliable info in a rapidly growing field. Enroll below👇

CPCR Faculty @existwell.bsky.social will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Wednesday 11/19 at 6pm 11 E. 33rd St

Over the weekend, CPCR hosted a satellite event to the 2025 @sfn.org conference. Researchers around the world gathered to discuss the latest advances in psychedelic neuroscience—sharing successes and challenges of translational models and exploring strategies to bridge preclinical and clinical work.

CPCR Medical Director, Dr. Sandeep Nayak spoke on a panel yesterday with Jada Pinket Smith at the Not Alone Summit in Las Vegas, discussing psychedelics and mental health

Dr. David Yaden will be speaking at MGH’s Psychedelics & Psychedelic Medicine Conference (Nov 14–15, virtual). Learn the latest research + earn CME/CE. Use code NET50 to save $50. Register: lms.mghcme.org/VirtualPsych...

Can psychedelics help us understand disease-related hallucinations? CPCR post doc Dr.Nate Heller @nate-h-heller.bsky.social explores how serotonin receptors might bridge psilocybin and Parkinson’s in @psychologytoday.com www.psychologytoday.com/us/blog/illu...

Last week, Drs. Weiss and Yaden joined a Humanities on the Hill panel after the film In Waves and War, discussing the impact of war on Veterans and the promise of psychedelic therapies, alongside Marcus Capone, Paul Shenk, and Dr. Virginia Jewiss.

‼️Healthy Volunteers Needed‼️ Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing). Apply or learn more: tinyurl.com/34jnz3d5 ☎️ 410-550-2253 | ✉️ [email protected]

CPCR members (Fred Barrett, Jessica Dyal, Tess Richardson) attended the kickoff meeting for Reunion Neuroscience’s REKINDLE trial, which will test RE-104—a shorter-acting psilocybin-like compound—for adjustment disorder. Stay tuned for recruitment updates!

🎬 Free Screening: In Waves and War — a documentary on three former Navy SEALs’ journeys with psychedelic therapy. 🗣️ Panel with Director Jon Shenk, Drs. Brandon Weiss & Bit Yaden, and Marcus & Amber Capone (VETS). 📅 Wed, Oct 29 | 6 PM 📍 JHU Bloomberg Center, DC 🎟️ Register Free

Dr. Fred Barrett presented preliminary data on psilocybin’s efficacy for treating depression with co-occurring alcohol use disorder and its underlying therapeutic mechanisms at the 38th annual ECNP Congress in Amsterdam.

🚨 There are limited spots left to attend the SfN Psychedelic Research Event 🧠 Join us before #SfN2025 (Friday, Nov 14) for a deep dive into cross-species psychedelic neuroscience. Register + speaker profiles👇 hopkinspsychedelic.org/sfn2025

Welcome our new postdoctoral research fellow, Dr. Eddie Jacobs. Dr. Jacobs comes to us from Oxford where he investigated ethical aspects of psychedelic therapies. At the CPCR, his work will explore how pre-existing worldviews & beliefs influence the quality and character of psychedelic experiences

🎙️ New podcast from @undarkmag: Dr. Albert Garcia-Romeu, joins Harvard’s Dr. Bertha Madras to discuss what we really know about psychedelics as medicine. 🔗 undark.org/2025/10/01/p...

🧠 New Psychedelic Article in Schizophrenia Bulletin! We argue that visual hallucinations in psychedelics and Lewy body disease may share common mechanisms ⇒ visual degradation & cortical excitation. academic.oup.com/schizophreni... Excited to see this spark discussion! #Neuroscience #Psychedelics

How do psychedelics help treat depression, anxiety, and addiction? In this #ECNP2025 preview, Drs. Linda Simmler and Frederick Barrett discuss psychedelic-induced plasticity with host Friederike Holze. 📅 See them live Oct 14, 2025, 8:40–10:00 🎧 www.youtube.com/watch?v=6FT2...

Dr. Brandon Weiss recently met with congressional staff, NIH, and federal regulators to discuss Veteran health and the importance of rigorous research in guiding safe, responsible psychedelic therapies.

🚨 ATTN SfN attendees: Join our pre-SfN event “The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience.” Limited spots—register now! 👉 hopkinspsychedelic.org/sfn2025